Coronary Stenosis

• 

  Subject Areas on Research

  • "Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is... ". 
  • 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. 
  • A practical approach to CT angiography of the neck and brain. 
  • A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study. 
  • A role of matrix metalloproteinase-8 in atherosclerosis. 
  • A spectrum of retinal vasculature measures and coronary artery disease. 
  • Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. 
  • Accuracy of multidetector computed tomography for detection of coronary artery stenosis in acute coronary syndrome compared with stable coronary disease: a CORE64 multicenter trial substudy. 
  • Addition of right-sided and posterior precordial leads during stress testing. 
  • Adenosine stress cardiac magnetic resonance imaging. 
  • Adjunctive use of cutting balloon after rotational atherectomy in a young adult with probable kawasaki disease. 
  • Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 
  • Applications and limitations of cardiac computed tomography in the evaluation of coronary artery disease. 
  • Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial. 
  • Assessment of contemporary stent deployment using intravascular ultrasound. 
  • Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. 
  • Atrial branch coronary artery stenosis as a mechanism for atrial fibrillation. 
  • Biological and analytical stability of a peripheral blood gene expression score for obstructive coronary artery disease in the PREDICT and COMPASS studies. 
  • Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. 
  • CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System.: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI). 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). 
  • Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia. 
  • Cardiopulmonary Bypass Management Complicated by a Stenotic Coronary Sinus and Cold Agglutinins. 
  • Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. 
  • Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trial. 
  • Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. 
  • Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment. 
  • Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction. 
  • Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? 
  • Clinical outcome as a function of the PR-interval-there is virtue in moderation: data from the Duke Databank for cardiovascular disease. 
  • Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. 
  • Clopidogrel dosing in overweight patients: does one size fit all? 
  • Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. 
  • Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. 
  • Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. 
  • Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. 
  • Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. 
  • Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. 
  • Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results. 
  • Coronary Circulatory Indexes Before and After Percutaneous Coronary Intervention in a Porcine Tandem Stenoses Model. 
  • Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. 
  • Coronary artery stents: evaluating new designs for contemporary percutaneous intervention. 
  • Coronary intervention for persistent occlusion after myocardial infarction. 
  • Coronary volume to left ventricular mass ratio in patients with diabetes mellitus. 
  • Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. 
  • Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain. 
  • Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. 
  • Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know? 
  • Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting. 
  • Detecting obstructive coronary disease with CT angiography and noninvasive fractional flow reserve. 
  • Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. 
  • Determinants of Rejection Rate for Coronary CT Angiography Fractional Flow Reserve Analysis. 
  • Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada. 
  • Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. 
  • Diagnostic accuracy of noninvasive testing: necessary but insufficient. 
  • Diagnostic impact of SPECT image display on assessment of obstructive coronary artery disease. 
  • Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. 
  • Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial. 
  • Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. 
  • Downstream coronary effects of drug-eluting stents. 
  • Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). 
  • Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. 
  • Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. 
  • Estimating the real-world performance of the PROMISE minimal-risk tool. 
  • Evaluating the Diagnostic Performance of Noninvasive Testing and the Perils of Inclusion Bias. 
  • Evaluation of ischemic heart disease. 
  • Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. 
  • FGF23: fashion or physiology? 
  • Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. 
  • Global Sensitivity Analysis For Clinically Validated 1D Models of Fractional Flow Reserve. 
  • Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial. 
  • High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial. 
  • Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. 
  • Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. 
  • Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial). 
  • Impact of computed tomography (CT)-derived fractional flow reserve on reader confidence for interpretation of coronary CT angiography. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. 
  • Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry. 
  • Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. 
  • Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry. 
  • Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. 
  • Instantaneous wave-free ratio guided multivessel revascularisation during percutaneous coronary intervention for acute myocardial infarction: study protocol of the randomised controlled iMODERN trial. 
  • Intraaortic balloon pump location and aortic dissection. 
  • Invited commentary. 
  • Left main coronary disease: evolving management concepts. 
  • Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. 
  • Long-Term Outcomes of Complete Revascularization With Percutaneous Coronary Intervention in Acute Coronary Syndromes. 
  • Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies. 
  • Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. 
  • Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. 
  • Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). 
  • Non-hyperaemic coronary pressure measurements to guide coronary interventions. 
  • Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. 
  • Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! 
  • Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. 
  • P2Y12 Receptor Blockade and Myocardial Perfusion. 
  • Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. 
  • Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. 
  • Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. 
  • Predictive Model for High-Risk Coronary Artery Disease. 
  • Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial. 
  • Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. 
  • Prevalence of Abnormal Coronary Findings on Coronary Computed Tomography Angiography Among Young Adults Presenting With Chest Pain. 
  • Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. 
  • Procedural Outcomes of Pulmonary Atresia With Intact Ventricular Septum in Neonates: A Multicenter Study. 
  • Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death. 
  • Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary Stenosis. 
  • Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. 
  • Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. 
  • Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. 
  • Quality of life after late invasive therapy for occluded arteries. 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. 
  • Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFRCT in Coronary Care (ADVANCE) registry. 
  • Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial). 
  • Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. 
  • Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). 
  • Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke? 
  • Reply: Influence of Target Vessel on Post-PCI iFR. 
  • Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. 
  • Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease. 
  • Role of coronary artery calcium score in identifying occult coronary artery disease in patients evaluated for deceased-donor liver transplant - a preliminary report. 
  • Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. 
  • Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. 
  • Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes. 
  • Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. 
  • Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE. 
  • Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy. 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. 
  • Sudden cardiac death in young children with neurofibromatosis type 1. 
  • Temporal changes in FFRCT-Guided Management of Coronary Artery Disease - Lessons from the ADVANCE Registry. 
  • The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. 
  • The VB-1 catheter: an improved catheter for difficult-to-engage internal mammary artery grafts. 
  • The clinical utility of FFRCT stratified by age. 
  • The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing. 
  • The contribution of hypertension to black-white differences in likelihood of coronary artery disease detected during elective angiography. 
  • The process of bringing new drug-eluting stents to market will they see the light of day? 
  • The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. 
  • The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography. 
  • The truth and consequences of the COURAGE trial. 
  • Trans-lesional fractional flow reserve gradient as derived from coronary CT improves patient management: ADVANCE registry. 
  • Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial. 
  • Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. 
  • Utility of observation units for young emergency department chest pain patients. 
  • Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. 
  • Wellens syndrome: a life-saving diagnosis. 
  • What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation? 
  • [Is coronary magnetic resonance angiography already a clinically useful diagnostic tool?]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology